By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Irish biotech and pharmaceutical services firm Icon and Proteome Sciences have agreed to collaborate to offer a biomarker discovery solution to assess new candidate drugs, Icon said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
The Wall Street Journal looks into the cost of new gene therapies.
An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.
In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.
This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.